Raja Roti Cemerlang Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Raja Roti Cemerlang Tbk. trades at Rp65 (market cap 64.65B, 8.88M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 33.3K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.5× Raja Roti Cemerlang Tbk.'s market cap, and Raja Roti Cemerlang Tbk. is more actively traded (8.88M versus 33.3K). Which is the better fit depends on your goals.
| BRRC | OBAT | |
|---|---|---|
Market Cap | 64.65B | 164.65B |
Volume | 8.88M | 33.3K |
Lot | 88.79K | 333 |
Turnover | 564.51M | 8.05M |
Average Price | 63.58 | 241.64 |
Value | 564.51M | 8.05M |
Indicative Equilibrium Price | 64 | 238 |
Indicative Equilibrium Volume | 577 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Raja Roti Cemerlang Tbk (the Company) was established based on Notarial Deed No. 5 dated September 21, 2015 of Dian Rohmah Yuniasari, S.H., M.Kn., notary in Bekasi. The Company begin its operation activities in 2015.
Read more on BRRC →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →